We are live on ! Find out more
PC

Polar Capital Portfolio holdings

AUM $13.5B
1-Year Est. Return 55.9%
This Fund
S&P 500
This Quarter Est. Return
+4.79%
1 Year Est. Return
+55.9%
3 Year Est. Return
+127.44%
5 Year Est. Return
+269.08%
10 Year Est. Return
–
AUM
$9.92B
AUM Growth
+$227M
Cap. Flow
-$128M
Cap. Flow %
-1.29%
Top 10 Hldgs %
23.77%
Holding
295
New
45
Increased
130
Reduced
64
Closed
40

Top Buys

Rank Stock Value
1
ACGL icon
Arch Capital
ACGL
+$79.5M
2
INTC icon
Intel
INTC
+$77.4M
3
HCA icon
HCA Healthcare
HCA
+$66M
4
MO icon
Altria Group
MO
+$62.4M
5
MRK icon
Merck
MRK
+$53.5M

Top Sells

Rank Stock Value
1
JNJ icon
Johnson & Johnson
JNJ
+$171M
2
VR
Validus Hold Ltd
VR
+$156M
3
BRK.B icon
Berkshire Hathaway Class B
BRK.B
+$76.7M
4
UNH icon
UnitedHealth
UNH
+$62.8M
5
NKTR icon
Nektar Therapeutics
NKTR
+$60.8M

Sector Composition

Rank Sector Weight
1 Technology 23.04%
2 Financials 22.63%
3 Healthcare 19.22%
4 Communication Services 10.44%
5 Industrials 7.54%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
BMRN icon
151
BioMarin Pharmaceuticals
BMRN
$12B
$17.2M 0.17%
212,300
-42,500
-17% -$3.65M
CBIO
152
Crescent Biopharma
CBIO
$608M
$16.7M 0.17%
10,291
+3,498
+51% +$7.27M
BDX icon
153
Becton Dickinson
BDX
$45.8B
$16.7M 0.17%
78,925
– –
RMD icon
154
ResMed
RMD
$30.3B
$16.4M 0.17%
+166,592
New +$15.7M
PNC icon
155
PNC Financial Services
PNC
$100B
$15.7M 0.16%
103,793
-4,874
-4% -$757K
TD icon
156
Toronto Dominion Bank
TD
$199B
$15.4M 0.16%
235,860
+1,350
+0.6% +$79K
PPLI
157
People Inc
PPLI
$3.13B
$14.9M 0.15%
531,967
+37,965
+8% +$1M
LLY icon
158
Eli Lilly
LLY
$1.09T
$14.6M 0.15%
+189,000
New +$15.2M
QVCGA
159
DELISTED
QVC Group Inc Series A
QVCGA
$14.4M 0.14%
11,746
+34
+0.3% +$44.7K
ALXN
160
DELISTED
Alexion Pharmaceuticals
ALXN
$13.9M 0.14%
125,000
-441,371
-78% -$52.8M
CSCO icon
161
Cisco
CSCO
$456B
$13.9M 0.14%
+325,200
New +$13.8M
FMI
162
DELISTED
Foundation Medicine, Inc.
FMI
$13.6M 0.14%
+173,000
New +$12.8M
ASMB icon
163
Assembly Biosciences
ASMB
$507M
$13.5M 0.14%
22,942
+10,417
+83% +$6.46M
MANU icon
164
Manchester United
MANU
$4.03B
$13.3M 0.13%
714,835
+48,639
+7% +$959K
AUPH icon
165
Aurinia Pharmaceuticals
AUPH
$1.92B
$13M 0.13%
2,500,000
+200,000
+9% +$1.07M
REGN icon
166
Regeneron Pharmaceuticals
REGN
$72.9B
$12.9M 0.13%
37,500
-2,500
-6% -$870K
SUPN icon
167
Supernus Pharmaceuticals
SUPN
$2.77B
$12.6M 0.13%
275,000
+75,000
+38% +$3.13M
WOLF icon
168
Wolfspeed
WOLF
$1.14B
$12.5M 0.13%
309,243
-124,957
-29% -$4.71M
MA icon
169
Mastercard
MA
$497B
$12.3M 0.12%
70,227
+3,373
+5% +$577K
FRC
170
DELISTED
First Republic Bank
FRC
$12.2M 0.12%
131,799
+3,528
+3% +$325K
ARCC icon
171
Ares Capital
ARCC
$13.7B
$11.6M 0.12%
731,732
+15,000
+2% +$238K
CNC icon
172
Centene
CNC
$31.6B
$11.5M 0.12%
215,000
-600,000
-74% -$31.3M
TMO icon
173
Thermo Fisher Scientific
TMO
$214B
$11.4M 0.12%
55,422
+35,603
+180% +$7.47M
TSRO
174
DELISTED
TESARO, Inc.
TSRO
$11.4M 0.12%
200,000
+60,000
+43% +$3.86M
GILD icon
175
Gilead Sciences
GILD
$167B
$11.3M 0.11%
+150,000
New +$11.9M
5 6
7
8 9

Similar funds

ECM
ETrade Capital Management Arlington, Virginia $5.37B AUM 10.84% 1-Year Est. Return
FAAS
First Allied Advisory Services San Diego, California $2.98B AUM 15.89% 1-Year Est. Return
WAM
Wealthspire Advisors (Maryland) Potomac, Maryland $2.84B AUM 10.91% 1-Year Est. Return
FS
Feinberg Stephen $2.61B AUM 15.12% 1-Year Est. Return
NIMC
NWQ Investment Management Company Los Angeles, California $2.22B AUM 6.84% 1-Year Est. Return
TI
TT International London, United Kingdom $1.94B AUM
VIM
Veritas Investment Management London, United Kingdom $1.65B AUM 25.54% 1-Year Est. Return
PS
Peter Svennilson $1.23B AUM 301.34% 1-Year Est. Return

Polar Capital's Q1 2018 Portfolio in Review

As of Q1 2018, Polar Capital held 295 positions worth $9.92B, up 2.3% from $9.69B the previous quarter. Its ten largest holdings account for 24% of the portfolio.

Polar Capital's Q1 2018 filing shows 45 new, 130 increased, 64 reduced and 40 closed positions. Its largest new stake was Intel: 1,627,806 shares worth $84.5M. The largest sale was Johnson & Johnson, an estimated $171M.

By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 19% a quarter earlier, followed by Financials and Healthcare.

  • Polar Capital's largest Q1 2018 buy was Intel: 1,627,806 shares worth $84.5M.
  • Polar Capital added most to Arch Capital in Q1 2018, an estimated $79.5M increase.
  • Polar Capital's biggest Q1 2018 reduction was Validus Hold Ltd, cutting an estimated $156M.
  • Polar Capital fully exited Johnson & Johnson in Q1 2018, selling an estimated $171M.
  • Polar Capital's ten largest holdings make up 24% of its $9.92B portfolio in Q1 2018.
  • Polar Capital opened 45 new positions and closed 40 in Q1 2018.
  • Polar Capital's portfolio value rose 2.3% quarter-over-quarter to $9.92B.

Based on Polar Capital's 13F filing for Q1 2018, filed 15 May 2018.